How could you make profits off the 5G phenomenon? Good day, everyone, What is 5G? First and foremost, 5G is going to change your life over the next de...
Some Value Stocks We are Watching in Potential Blockbuster Markets
DevMar Equities, Inc. (OTC: DEVM) acquires, develops and operates high rise, multi-family/mixed use and hospitality properties with a focus on Florida...
Whether You Smoke It, Toke It or Drink It – These Cannabis and CBD Companies Want Your Business
22nd Century Group, Inc. (NYSE: XXII) has been developing Very Low Nicotine (VLN) cigarettes for a long time and they are getting very close to market...
Cutting Edge Pipeline, 2019 NASDAQ IPO
IPO closed in February 2019 Hoth has exclusive worldwide rights to the BioLexa Platform. Good day everyone, Today we are initiating coverage of Hoth T...
Recently Public Providing Exclusive Product Lines for Disney’s Star Wars, Avatar and More
Edison Nation, Inc. (NASDAQ: EDNT) Edison Nation is a vertically-integrated, end-to-end, consumer product research and development, manufacturing, sal...
Special Weekend Podcast: Ed Karr, CEO of U.S. Gold Corp. (NASDAQ: USAU)
Source – TFMetalsReport.com https://www.tfmetalsreport.com/podcast/9436/special-weekend-podcast-ed-karr-ceo-us-gold-corp The above CEO interview...
Traders News Source is Evaluating the Three Wheel Electric Vehicles Market
Arcimoto, Inc has established a unique business model focused on building Fun Utility Vehicle, Rapid Responder, and Deliverator are some of the lighte...
What Does Bridgeline Digital Look Like After Multiple Asset Acquisitions
Bridgeline Digital, Inc. (NASDAQ: BLIN) operates as a digital engagement company. The company provides digital strategy, Web design and development, u...
Biotech News, What Milestones and Catalysts Could Drive BioLineRx Shares in 2019
BioLineRx Ltd. (NASDAQ: BLRX) is a clinical stage biopharmaceutical development company, focused on oncology and immunology. The Company in-licenses n...
Hemispherx To Be Transparent on the Development of Ampligen and Announced Significant Progress
Hemispherx Biopharma, Inc. (NYSE: HEB) is a specialty pharmaceutical company, engaged in the clinical development of drug therapies based on natural i...